{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-25-046436","form_type":"8-K","ticker":"ORMP","cik":"0001176309","company_name":"ORAMED PHARMACEUTICALS INC.","filed_at":"2025-05-21T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.709133+00:00","generated_at":"2026-05-20T22:13:33.858679+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Oramed extends $20M stock buyback program through June 2026","bullets":["Board extended share repurchase program by one year, now expiring June 2026.","Maximum authorization remains $20M; $2.494M in shares repurchased to date.","Repurchases may occur via open market or private transactions; no obligation to buy.","Board may terminate, increase, or decrease authorization at any time."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-25-046436","json":"https://secwatch.observer/filing/0001213900-25-046436.json","markdown":"https://secwatch.observer/filing/0001213900-25-046436.md","text":"https://secwatch.observer/filing/0001213900-25-046436.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025046436/0001213900-25-046436-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1176309/000121390025046436/ea0243059-8k_oramed.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T22:13:33.858679+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}